Ning - medtechiq.ning.com - Latest Activity on MedTechIQ "Network"
General Information:
Latest News:
OptiMedica, Corp.: Series E $35M 10 May 2013 | 12:00 pm
OptiMedica (Sunnyvale, CA), a commercial-stage medical device company focused on laser technology for cataract surgery, closed a $35M Series E financing. Participants include Kleiner Perkins Caufield ...
iRythm Technologies, Inc.: Series C $1.5M 9 May 2013 | 12:00 pm
iRhythm Technologies (San Francisco, CA), a commercial-stage medical device company that focused on cardiac rhythm monitoring, closed a $1.5M Series C financing. Participants include the California He...
Edison Pharmaceuticals, Inc.: Series F $20M 8 May 2013 | 12:00 pm
Edison Pharmaceuticals (Mountain View, CA), a clinical-stage pharmaceutical company developing small molecules to treat mitochondrial disease, closed a $20M Series F financing. Participants include Mi...
New Haven Pharmaceuticals, Inc.: Series A $6.6M 7 May 2013 | 08:46 am
New Haven Pharmaceuticals (New Haven, CT), a specialty pharmaceutical company focused on a slow release aspirin product, closed a $6.6M Series A. Participants include Connecticut Innovations and priva...
Kiadis Pharma, B.V.: Series D $12.8M 6 May 2013 | 09:13 am
Kiadis Pharma (Netherlands), a clinical-stage biopharmaceutical company developing treatments for blood cancers, closed a $12.8M Series D financing. Participants include Life Sciences Partners, DFJ-Es...
Synovex Corporation: Series C $3.5M 3 May 2013 | 12:00 pm
Synovex (Boston, MA), a clinical stage biotechnology company focused on inhibiting the progression of fibrotic diseases such as arthritis, closed a $3.5M Series C financing. Participants were not iden...
Neurovance, Inc.: Series A $7M 2 May 2013 | 12:00 pm
Neurovance (Cambridge, MA), a clinical stage pharmaceutical company developing a norepinephrine, dopamine and serotonin triple uptake inhibitor to treat ADHD, closed a $7M Series A financing. Particip...
Cebix, Inc.: Series B $30.9M 2 May 2013 | 12:00 pm
Cebix (San Diego, CA), a clinical stage biotechnology company developing a modified insulin C-peptide for the treatment of complications associated with diabetes such as peripheral neuropathy, closed ...
Qinec, Ltd.: Series B $2.5M 1 May 2013 | 12:00 pm
Qinec (United Kingdom), a Health IT company developing tools for web-based medical practice management, closed a $2.5M Series B financing. Participants include Amadeus Capital Partners and Archimedia ...
Biophytis, SAS: Series B $2.6M 1 May 2013 | 12:00 pm
Biophyti (France), a clinical stage pharmaceutical company developing a portfolio of nutraceuticals and drug candidates derived from active natural substances to treat metabolic disorders and age rela...
